tiprankstipranks
Structure Therapeutics, Inc. Sponsored ADR (GPCR)
NASDAQ:GPCR
US Market
GPCR
Structure Therapeutics, Inc. Sponsored ADR
RESEARCH TOOLSreports
Want to see GPCR full AI Analyst Report?

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Stock News & Sentiment

1,274 Followers
Analyst Maintains Buy on Strong Aleniglipron Data and 2026 Catalysts, Modestly Trimming Price Target to $104
Premium
Ratings
Analyst Maintains Buy on Strong Aleniglipron Data and 2026 Catalysts, Modestly Trimming Price Target to $104
16d ago
GPCR
Structure Therapeutics Expands ATM Capacity, Advances Obesity Program
Premium
Company Announcements
Structure Therapeutics Expands ATM Capacity, Advances Obesity Program
17d ago
8K
GPCR
Kailera Stock (KLRA) Rockets 68% after IPO in Race for $150B Obesity Market
Premium
Market News
Kailera Stock (KLRA) Rockets 68% after IPO in Race for $150B Obesity Market
1M ago
LLY
PFE
Structure Therapeutics Appoints Matthew Lang as Chief Operating Officer
Premium
Company Announcements
Structure Therapeutics Appoints Matthew Lang as Chief Operating Officer
1M ago
8K
GPCR
Buy Rating on GPCR Driven by Competitive Aleniglipron Phase 2b Efficacy and Clear Path to Phase 3 in Obesity
Premium
Ratings
Buy Rating on GPCR Driven by Competitive Aleniglipron Phase 2b Efficacy and Clear Path to Phase 3 in Obesity
2M ago
GPCR
Buy Rating on Structure Therapeutics: Aleniglipron’s Strengthening Clinical Profile and Undervalued Global Obesity Opportunity
Premium
Ratings
Buy Rating on Structure Therapeutics: Aleniglipron’s Strengthening Clinical Profile and Undervalued Global Obesity Opportunity
2M ago
GPCR
Structure Therapeutics Reports Strong Phase 2 Obesity Drug Results
Premium
Company Announcements
Structure Therapeutics Reports Strong Phase 2 Obesity Drug Results
2M ago
8K
GPCR
More GPCR News >

GPCR News on the Web

This Obesity Drug Stock Has Jumped 60% as Phase 3 Plans Advance. A Fund Just Sold $4.7 Million
The Motley Fool
Bullish
Analysts’ Top Healthcare Picks: Olema Pharmaceuticals (OLMA), Structure Therapeutics, Inc. Sponsored ADR (GPCR)
TipRanks News
Neutral
Structure Therapeutics, Inc. Sponsored ADR (GPCR) Gets a Buy from Cantor Fitzgerald
TipRanks News
Bullish
Analyst Maintains Buy on Strong Aleniglipron Data and 2026 Catalysts, Modestly Trimming Price Target to $104
TipRanks News
Bullish
Canaccord Genuity Sticks to Their Buy Rating for Structure Therapeutics, Inc. Sponsored ADR (GPCR)
TipRanks News
Bullish
Structure Therapeutics, Inc. Sponsored ADR (GPCR) Receives a Buy from Guggenheim
TipRanks News
Bullish
Structure Therapeutics Expands ATM Capacity, Advances Obesity Program
TipRanks News
Neutral
Analysts Are Bullish on These Healthcare Stocks: Definitive Healthcare Corp (DH), Astrana Health (ASTH)
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
GPCR
Sector Average
Media Buzz
This Week2 articles
Weekly Average2.75 articles
News Sentiment
This Week79%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GPCR’s Media Buzz Sentiment?
2 articles about GPCR were published this week. In an average week, 2.75 articles are published.
    What is GPCR’s weekly average amount of articles?
    In an average week, 2.75 articles about GPCR are published.
      What is GPCR’s News Sentiment?
      79% of articles about GPCR were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        TLSATiziana Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week